Related Experiment Video
Updated: Jun 18, 2025

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
HELICOBACTER PYLORI AND GALLBLADDER PATHOLOGIES: IS THERE A CAUSE-AND-EFFECT RELATIONSHIP?
L Gulbani1, L Svanadze2, I Jikia3
11Ivane Javakhishvili Tbilisi State University (TSU); 4Caucasus International University, Tbilisi, Georgia.
Helicobacter pylori infection was not directly linked to gallbladder diseases like cholecystitis or polyps. Elevated chemokines CXCL2 and CXCL5 were found, but not associated with H. pylori presence.
Area of Science:
- Gastroenterology
- Pathology
- Microbiology
Background:
- The association between Helicobacter pylori (H. pylori) infection and gallbladder diseases, including cholecystitis and gallbladder polyps, is not well-defined.
- Investigating H. pylori's role in gallbladder pathologies and its impact on chemokine expression is crucial for understanding disease mechanisms.
Purpose of the Study:
- To determine the prevalence of H. pylori in gallbladder tissues.
- To assess the expression of chemokines CXCL2 and CXCL5 in patients with gallbladder diseases.
- To explore the potential relationship between H. pylori infection, chemokine expression, and gallbladder pathologies.
Main Methods:
- Analysis of 137 laparoscopically excised gallbladders.
- Histological examination and PCR for H. pylori detection.
- Quantitative real-time PCR for CXCL2 and CXCL5 gene expression analysis in patients with acute calculous cholecystitis, chronic calculous cholecystitis, and gallbladder polyps.
Main Results:
- H. pylori was detected in 30.7% (histology) and 42.3% (PCR) of gallbladder tissues.
- Elevated CXCL2 and CXCL5 expression was observed in 62% and 57.7% of cases, respectively, notably higher in acute cholecystitis.
- No statistically significant association was found between H. pylori presence and cholecystitis types or chemokine expression.
Conclusions:
- This study did not establish a direct causal link between H. pylori infection and gallbladder pathologies.
- The upregulation of CXCL2 and CXCL5 in gallbladder diseases may be influenced by factors other than H. pylori.
- Further research is warranted to clarify the complex interplay between H. pylori, chemokines, and gallbladder disease pathogenesis.
More Related Videos
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

